ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2022 American Transplant Congress

    Liver Transplant Outcomes Using Grafts with Early Allograft Dysfunction

    S. Y. Ohara1, E. Macdonough2, G. Mahdi3, L. Egbert3, B. Lizaola-Mayo2, W. Hewitt4, A. Mathur4, A. Moss4, K. Reddy4, B. Aqel4, C. Jadlowiec4

    1Division of Surgery, Valleywise Health Medical Center, Creighton University, Phoenix, AZ, 2Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, Phoenix, AZ, 3Mayo Clinic Alix School of Medicine, Phoenix, AZ, 4Division of Transplant Surgery, Mayo Clinic Arizona, Phoenix, AZ

    *Purpose: The significance of early allograft dysfunction (EAD) and its impact on liver transplant (LT) outcomes remains debated. Our study aimed to assess LT outcomes…
  • 2022 American Transplant Congress

    Donor Exercise Preconditioning Protects Murine Orthotopic Liver Grafts During Ischemia Reperfusion Injury

    H. O. Yazdani, C. Kaltenmeier, R. Nakano, R. L. Simmons, D. A. Geller, S. Tohme

    Surgery, University of Pittsburgh Medical Center, Pissburgh, PA

    *Purpose: Orthotopic liver transplantation (LTx) serves as the gold standard of care in patients with end-stage liver disease. However, a major obstacle to the immediate…
  • 2022 American Transplant Congress

    Safety and Efficacy of a Probiotic Protocol to Reduce Perioperative Infection After Liver Transplantation

    M. Jorgenson, Q. Yang, G. Leverson, C. Saddler, J. Smith, N. Safdar, D. Al-Adra

    University of Wisconsin Health, Madison, WI

    *Purpose: Evaluate efficacy and safety of a probiotic preparation to reduce perioperative infection in patients undergoing liver transplant surgery*Methods: Adult patients receiving liver transplantation from…
  • 2022 American Transplant Congress

    Higher Baseline Serum Creatinine Levels AreAssociated with an Increased Incidence of Renal Replacement Therapy in Patients with Hepatorenal Syndrome Type 1 on the Liver Transplant Waitlist

    S. N. Sclair1, A. Befeler2, K. Jamil3

    1Hepatology, University Hospitals Cleveland Medical Center & Case Western Reserve University, Cleveland, OH, 2Gastroenterology, Hepatology, Transplant Hepatology, Saint Louis University School of Medicine, St Louis, MO, 3Hepatology, Mallinckrodt Pharmaceuticals, Clinton, NJ

    *Purpose: Pretransplant and posttransplant renal replacement therapy (RRT) is associated with increased morbidity and mortality in liver transplant recipients, including those with Hepatorenal syndrome type…
  • 2022 American Transplant Congress

    Surging Liver Transplant Rates for Alcohol-Associated Liver Disease May Exacerbate Waitlist Death of Patients with Hepatocellular Carcinoma in MMAT-3 Era

    L. Yuan1, J. L. Dodge1, K. Zhou1, N. Terrault2

    1Division of Gastrointestinal and Liver Diseases, University of Southern California, Los Angeles, CA, 2University of Southern California, Los Angeles, CA

    *Purpose: Rates of liver transplantation (LT) for alcohol-associated liver disease (ALD) have increased significantly, in part related to broader acceptance of severe alcohol hepatitis (AH)…
  • 2022 American Transplant Congress

    Failure to Account for Social Determinants of Health in Non-HCC MELD Exceptions Exacerbates Geographic Disparities in Access to Liver Transplantation

    R. M. Cannon, P. MacLennan, S. S. Sheikh, B. J. Orandi, A. Nasell, J. T. Walker, J. E. Locke

    University of Alabama at Birmingham, Birmingham, AL

    *Purpose: Non-HCC MELD exceptions have been previously shown to give excess priority for transplant in certain UNOS Regions, but this phenomenon has not been examined…
  • 2022 American Transplant Congress

    Knowledge, Attitude, and Practices Regarding Covid-19 Among Solid Organ Transplant Patients at a Transplant Center in the United States: A Cross-Sectional Study

    L. Wang, H. Oduor, M. Abualfoul, P. Acharya, M. Pagadala

    Methodist Dallas Medical Center, Dallas, TX

    *Purpose: To evaluate the knowledge, attitude, and practices (KAP) of patients who have undergone kidney and/or liver solid organ transplants (SOTs) during the COVID-19 pandemic.*Methods:…
  • 2022 American Transplant Congress

    Development of a Portable Device to Quantify Hepatic Steatosis in Donated Livers Using an AI Algorithm

    S. Klinkachorn1, C. J. Tsoi-A-Sue2, R. R. Narayan2, M. L. Melcher2

    1Computer Science, Stanford, Stanford, CA, 2Surgery, Stanford, Stanford, CA

    *Purpose: An accurate estimation of liver fat content is necessary to predict how a donor liver will function after transplantation. This can be challenging at…
  • 2022 American Transplant Congress

    Development Process of Minimally Invasive Living Donor Liver Transplantation (from Pure Laparoscopic Explant Hepatectomy to Robotic Graft Implantation)

    K. Suh, S. Hong, S. Lee, S. Suh, S. Hong, E. Han, Y. Choi, N. Yi, K. Lee

    Surgery, Seoul National University College of Medicine, Seoul, Korea, Republic of

    *Purpose: With the accumulation of experience in pure laparoscopic hepatectomy, including donor hepatectomy, our center initiated a minimally invasive living donor liver transplantation (LDLT) program…
  • 2022 American Transplant Congress

    Bariatric Surgery and Alcohol Related Steatohepatitis (BASH): An Increasing Etiology in Pre-Liver Transplant Candidates

    S. Nishida1, K. Okumura1, A. Dhand2, R. Bodin2, S. Yaghoubian3, C. Greenberg1, R. Misawa1, G. Veillette1, H. Sogawa1, D. John1, D. C. Wolf2, B. Partiula2, T. Diflo1, R. Latifi1, S. Lansman1

    1Surgery, Westchester Medical Center/ New York Medical College, Valhalla, NY, 2Medicine, Westchester Medical Center/ New York Medical College, Valhalla, NY, 3Anesthesia, Westchester Medical Center/ New York Medical College, Valhalla, NY

    *Purpose: Obesity-related fatty liver disease and non-alcoholic steatohepatitis (NASH) are common causes of End-stage liver disease (ESLD). Bariatric surgery (BS) is commonly indicated for these…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences